Step 2 - Identify the right programme

Types of research, evidence and scale

Light bulb icon
  • Programme suitability depends on your broad research area, type of evidence (synthesis or generation) and scale (an individual project or study or a linked programme of research).
  • Our programmes are open to any rigorous design that addresses a question within its remit including (but not only), evidence synthesis, pilot and feasibility studies, randomised controlled trials and both quantitative and qualitative research.
  • Check what we have funded before.
  • The type of research and evidence within each programme’s remit is given below, with the Policy Research Programme (PRP) commissioning research and and working closely with the Department of Health and Social Care to support policy makers in England to make informed decisions for the benefit of the general population, patients and the NHS. 

Find out more about a specific programme: EME Efficacy and Mechanism Evaluation; HS&DR Health Services and Delivery Research; HTA Health Technology Assessment; i4i Invention for Innovation; PRP Policy Research Programme (NB not yet included in table above or below); PGfAR Programme Grants for Applied Research; PDG Programme Development Grants; PHR Public Health Research; RfPB Research for Patient Benefit; SR Systematic Reviews. 

Types of call and funding limits

All funding opportunities are listed on this website and you can sign up to funding alerts to be notified of new opportunities. The number of opportunities to apply, and the funding limits, are given below by research programme.

Notes: *Subject to change. **Applicants must fully justify all costs. ***Period and level of funding depends on nature of proposed work, in particular whether a fully powered evaluative study is included - funding above £2.5 million will be unusual. Programmes terminating in feasibility studies will be unlikely to receive more than £500,000. †Feasibility studies are expected to cost less than £250,000 and proposals which will generate results that may be useful for more downstream investigations are expected to cost less than £150,000.